Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) rose 1% during mid-day trading on Wednesday. The stock traded as high as $1.07 and last traded at $1.05. 370,812 shares traded hands during trading, an increase of 453% from the average daily volume of 67,097 shares. The stock had previously closed at $1.04.
Cardiol Therapeutics Stock Up 1.0%
The business has a 50 day simple moving average of $1.59 and a 200-day simple moving average of $1.29.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a Canadian clinical-stage biotechnology company focused on developing anti-inflammatory therapies for diseases of the heart and related conditions. The company’s research is centered on the therapeutic potential of cannabidiol and other compounds that may help reduce inflammation and fibrosis, or scarring, in cardiovascular tissues.
Its lead investigational product, CardiolRx, is an oral pharmaceutical formulation of cannabidiol that does not contain the intoxicating cannabinoid THC.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
